Xenetic Biosciences Q3 EPS $(0.69) Beats $(1.12) Estimate, Sales $611.17K Beat $460.00K Estimate
Xenetic Biosciences Q3 EPS $(0.69) Beats $(1.12) Estimate, Sales $611.17K Beat $460.00K Estimate
Xenetic Biosciences 第三季度每股收益（0.69 美元）高於美元（1.12）的預期，銷售額爲61.17萬美元，超過了預期的4.6萬美元
Xenetic Biosciences (NASDAQ:XBIO) reported quarterly losses of $(0.69) per share which beat the analyst consensus estimate of $(1.12) by 38.39 percent. This is a 15 percent decrease over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $611.17 thousand which beat the analyst consensus estimate of $460.00 thousand by 32.86 percent. This is a 47.54 percent increase over sales of $414.25 thousand the same period last year.
Xenetic Biosciences（納斯達克股票代碼：XBIO）公佈季度每股虧損0.69美元，比分析師普遍估計的1.12美元（1.12美元）高出38.39％。這比去年同期每股虧損0.60美元（0.60美元）下降了15％。該公司公佈的季度銷售額爲611,170美元，比分析師普遍估計的46萬美元高出32.86％。這比去年同期的414,250美元的銷售額增長了47.54％。